Itaconix PLC
LSE:ITX

Watchlist Manager
Itaconix PLC Logo
Itaconix PLC
LSE:ITX
Watchlist
Price: 119.5 GBX Market Closed
Market Cap: 16.1m GBX

Itaconix PLC
Investor Relations

Itaconix Plc engages in designing, developing, and formulating novel polymers to improve the performance of existing consumer products. The company is headquartered in Deeside, Flintshire/Sir Fflint and currently employs 11 full-time employees. The company went IPO on 2012-07-10. The firm's bio-based specialty polymers is focused on improving the safety, performance and sustainability of consumer and industrial products. Itaconix has established a range of polymer ingredients for application in cleaning and hygiene, energy and industry, surface coatings and agriculture. The firm's products are categorized into two markets: homecare and industrial, and personal care. Its homecare and industrial products include Itaconix TSI 322, Itaconix DSP 2K, Itaconix CHT 122, Itaconix Zinador 22L, Itaconix Zinador 35L and Itaconix Velasoft. The firm's personal care products include Itaconix Velafresh ZP20, Itaconix Velafresh ZP30 and Itaconix Amaze SP.

Show more
Loading
ITX
FTSE All Share Index
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q2 2025
Call Date
Sep 15, 2025
AI Summary
Q2 2025

Record Revenue: Itaconix delivered record H1 2025 sales of $4.8 million, up 73% from H1 2024, and up 20% from its previous half-year record.

Gross Profit Growth: Gross profit reached $1.7 million, maintaining a 35% margin and up by $600,000 from the prior year.

Improved EBITDA: Adjusted EBITDA loss narrowed to $200,000 from $800,000 in H1 2024, showing significant progress toward breakeven.

Strong Cash Position: The company ended the period with $6.6 million in net working capital, confident it has resources to reach profitability.

North America Leads: 68% of sales came from North America, with major growth driven by the detergent sector and SPARX program.

SPARX Program Expansion: SPARX formulation solutions revenue rose 156% to $1.5 million, with 10 new products expected in market by year-end.

Outlook Positive: Management remains optimistic for 2025 and 2026, targeting profitability and expansion into new product lines and geographies.

Key Financials
Revenue
$4.8 million
Gross Profit
$1.7 million
Gross Profit Margin
35%
Adjusted EBITDA
-$200,000
Net Working Capital
$6.6 million
Performance Ingredients Revenue
$3.3 million
Performance Ingredients Gross Profit Margin
45%
SPARX Formulation Solutions Revenue
$1.5 million
SPARX Gross Profit Margin
13%
Fixed Asset Turn Ratio
9x
Working Capital Days
87 days
Cash Equivalents
$5.7 million
Sales in North America
$3.3 million
Sales in Europe and Global
$1.5 million
Other Earnings Calls
2025
2022

Management

Mr. John Roger Shaw MBA
Co-Founder, CEO & Director
No Bio Available
Ms. Laura Elizabeth Denner
CFO & Executive Director
No Bio Available
Dr. Yvon G. Durant MBA, Ph.D.
Co-Founder & CTO
No Bio Available
Monna Manning
Vice President of Marketing & Sales
No Bio Available

Contacts

Address
FLINTSHIRE/SIR FFLINT
Deeside
Zone 2, 1 Newtech Square
Contacts
+441244283500.0
itaconix.com